Compare iShares Global Tech ETF (IXN) vs UnitedHealth Group Inc (UNH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares Global Tech ETF vs UnitedHealth Group Inc — how do they compare? iShares Global Tech ETF trades at $136.82, while UnitedHealth Group Inc trades at $431.99 (market cap $396.27B). The key difference: UnitedHealth Group Inc pays a 2.13% dividend while iShares Global Tech ETF pays none, and UnitedHealth Group Inc is trading nearer its 52-week high, iShares Global Tech ETF nearer its low. Which is the better fit depends on your goals.
| IXN | UNH | |
|---|---|---|
Sector | Sector/Thematic | Health |
52-Week High | $149.74 | $436.35 |
52-Week Low | $94.04 | $237.77 |
Market Cap | — | $396.27B |
Enterprise Value | — | $442.96B |
Dividend Yield | — | 2.13% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IXN trades at $132.95, up 0.25% on the day, with technical indicators showing a bearish trend from moving averages and a neutral stance from oscillators. The stock faces resistance near $134 and support at $132. Recent news highlights its strong tech exposure but cautions that valuations may already reflect high expectations.
The outlook for IXN is mixed, with opportunities in global tech leadership and AI-driven growth, but risks include stretched valuations and concentration in tech. Analyst sentiment leans cautious, emphasizing the need for clearer earnings growth or a more attractive entry point for investment.
UnitedHealth Group (UNH) trades at $421.55, down 1.07% on the day, with a bullish technical outlook supported by moving averages and ADX signals. The company reported strong Q2 2026 EPS of $6.38, beating estimates, and maintains robust cash flow generation. Recent news highlights strategic moves to reduce pediatric prior authorizations and ongoing shareholder returns through dividends and buybacks.
UNH presents a favorable investment case with 82.7% analyst buy ratings and a $476.50 consensus price target, implying 13% upside. Risks include regulatory scrutiny from lawsuits and Medicaid fraud allegations, while demographic trends and operational efficiency support long-term growth. The stock's valuation at a P/E of 31.74 reflects premium pricing relative to historical margins.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About iShares Global Tech ETF
IXN provides exposure to global electronics, software, and hardware companies. It tracks the S&P Global 1200 Information Technology Index, covering tech leaders across both developed and emerging markets.
Read more on IXN →About UnitedHealth Group Inc
UnitedHealth Group is one of the largest private health insurers, providing medical benefits to 50 million members globally, including 5 million outside the U.S. at the end of 2021. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.
Read more on UNH →
